-The Economic Times The government has allowed a local drugmaker to make and sell a patented cancer drug at a fraction of the price charged by Germany's Bayer AG, setting a precedent for more such efforts by Indian firms and heightening the global pharmaceutical industry's anxiety over the use of the controversial compulsory licensing provision.  The outgoing patent controller of India, PH Kurian, on Monday granted the country's first compulsory licence to...

-Reuters India's move to strip German drugmaker Bayer of its exclusive rights to a cancer drug has set a precedent that could extend to other treatments, including modern HIV/AIDS drugs, in a major blow to global pharmaceutical firms, experts say.  On Monday, the Indian Patent Office effectively ended Bayer's monopoly for its Nexavar drug and issued its first-ever compulsory license allowing local generic maker Natco Pharma to make and sell the drug...

The myth that Fukushima radiation levels were too low to harm humans persists, a year after the meltdown.  A March 2, 2012 New York Times article quoted Vanderbilt University professor John Boice: “there’s no opportunity for conducting epidemiological studies that have any chance for success – the doses are just too low.”  Wolfgang Weiss of the UN Scientific Committee on the Effects of Atomic Radiation also recently said doses observed...

Closed mines and resultant unemployment are still stoking Naxalism in Saranda, a maiden jan adalat (public hearing) held 160km from the steel city insisted today, indicating that more needed to be done to make the much-touted central action plan for the red turf a long-lasting success. More than 1,000 villagers from the Maoist dens of Noamundi, Gua, Kiriburu and Barajamda among others, which fall in the mining belt of Saranda command...

Parliament must use budget session to discuss key pending bills The budget session of Parliament begins today. The last few sessions have been characterised by disruptions and consequent loss of productive time. To see one indicator, the 15th Lok Sabha, half-way through its term, has lost 30 per cent of scheduled time — the worst ever. As a result, many important bills have been pending. It is to be seen whether...